Scopus BioPharma Inc.
SCPS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2 | $28 | $198 | $89 |
| - Cash | $0 | $8 | $2 | $0 |
| + Debt | $0 | $0 | $2 | $0 |
| Enterprise Value | $2 | $20 | $199 | $89 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$26 | -$10 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$28 | -$12 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.55 | -1.61 | -0.87 | -0.18 |
| % Growth | 65.8% | -85.1% | -383.3% | – |
| Operating Cash Flow | -$8 | -$11 | -$3 | -$2 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$8 | -$11 | -$3 | -$2 |